{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:18:23Z","timestamp":1780373903524,"version":"3.54.1"},"reference-count":47,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T00:00:00Z","timestamp":1673481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MIUR Progetti di Ricerca di Rilevante Interesse Nazionale (PRIN)","award":["2017MHJJ55"],"award-info":[{"award-number":["2017MHJJ55"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Conventional chemotherapy represents the main systemic treatment used for triple-negative breast cancer (TNBC) patients, although many of them develop drug resistance. The hypoxic TME is the crucial driver in the onset of insensitivity to chemotherapy. In this research, we elucidated the role played by bone marrow-derived mesenchymal stem cells (BM-MSCs) in reducing cisplatin effects in TNBC. BT-549 and MDA-MB-231 cells, grown under hypoxic conditions in the presence of conditioned medium obtained from BM-MSCs (CM-MSCs), showed a strong cisplatin insensitivity and increased expression levels of carbonic anhydrase IX (CA IX). Therefore, we inhibited CM-MSC-induced CA IX by SLC-0111 to potentiate chemotherapy efficacy in TNBC cells. Our results showed that CM-MSCs under hypoxic conditions caused an increase in the ability of TNBC cells to form vascular structures, migrate and invade Matrigel. Cell treatment with cisplatin plus SLC-0111 was able to block these mechanisms, as well as the signaling pathways underlying them, such as p-AKT, p-ERK, CD44, MMP-2, vimentin, \u03b2-catenin, and N-cadherin, more effectively than treatment with single agents. In addition, a significant enhancement of apoptosis assessed by annexin V, caspase-3 expression and activity was also shown. Taken together, our results demonstrated the possibility, through CA IX inhibition, of returning TNBC cells to a more chemosensitive state.<\/jats:p>","DOI":"10.3390\/cells12020298","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T02:29:57Z","timestamp":1673576997000},"page":"298","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inhibition of Bone Marrow-Mesenchymal Stem Cell-Induced Carbonic Anhydrase IX Potentiates Chemotherapy Efficacy in Triple-Negative Breast Cancer Cells"],"prefix":"10.3390","volume":"12","author":[{"given":"Annachiara","family":"Sarnella","sequence":"first","affiliation":[{"name":"Institute of Biostructures and Bioimaging, CNR, 80145 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1939-6653","authenticated-orcid":false,"given":"Ylenia","family":"Ferrara","sequence":"additional","affiliation":[{"name":"Institute of Biostructures and Bioimaging, CNR, 80145 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Albanese","sequence":"additional","affiliation":[{"name":"Institute of Biostructures and Bioimaging, CNR, 80145 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8710-2971","authenticated-orcid":false,"given":"Daniela","family":"Omodei","sequence":"additional","affiliation":[{"name":"Institute of Biostructures and Bioimaging, CNR, 80145 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7633-7932","authenticated-orcid":false,"given":"Laura","family":"Cerchia","sequence":"additional","affiliation":[{"name":"Institute of Experimental Endocrinology and Oncology \u201cG. Salvatore\u201d, CNR, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9783-5431","authenticated-orcid":false,"given":"Giuseppina","family":"De Simone","sequence":"additional","affiliation":[{"name":"Institute of Biostructures and Bioimaging, CNR, 80145 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Department of Neurofarba, University of Florence, 50019 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6753-3659","authenticated-orcid":false,"given":"Antonella","family":"Zannetti","sequence":"additional","affiliation":[{"name":"Institute of Biostructures and Bioimaging, CNR, 80145 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer\u2014Expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"730815","DOI":"10.3389\/fonc.2021.730815","article-title":"Editorial: Tumor Microenvironment: Molecular Mechanisms and Signaling Pathways Involved in Metastatic Progression","volume":"11","author":"Link","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumor microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrc1477","article-title":"Friends or foes\u2014Bipolar effects of the tumor stroma in cancer","volume":"4","author":"Mueller","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-13-0661","article-title":"Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"73296","DOI":"10.18632\/oncotarget.20265","article-title":"Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype","volume":"8","author":"Hill","year":"2017","journal-title":"Oncotarget"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semcancer.2022.09.002","article-title":"Mesenchymal stem\/stromal cells in breast cancer development and management","volume":"86","author":"Tu","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.7150\/thno.18974","article-title":"Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFR\u03b2 Aptamer","volume":"7","author":"Camorani","year":"2017","journal-title":"Theranostics"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Sarnella, A., D\u2019Avino, G., Hill, B.S., Alterio, V., Winum, J.Y., Supuran, C.T., De Simone, G., and Zannetti, A. (2020). A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity. Int. J. Mol. Sci., 921.","DOI":"10.3390\/ijms21218405"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: Three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13543784.2021.2014813","article-title":"Carbonic anhydrase inhibitors: An update on experimental agents for the treatment and imaging of hypoxic tumors","volume":"30","author":"Supuran","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"McDonald, P.C., Chafe, S.C., Supuran, C.T., and Dedhar, S. (2022). Cancer Therapeutic Targeting of Hypoxia Induced Carbonic Anhydrase IX: From Bench to Bedside. Cancers, 14.","DOI":"10.3390\/cancers14143297"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8740294","DOI":"10.1155\/2017\/8740294","article-title":"Quality Evaluation of Human Bone Marrow Mesenchymal Stem Cells for Cartilage Repair","volume":"2017","author":"Shiraishi","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6241","DOI":"10.1002\/jcp.26493","article-title":"Autocrine signals increase ovine mesenchymal stem cells migration through Aquaporin-1 and CXCR4 overexpression","volume":"233","author":"Pelagalli","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00109-017-1590-9","article-title":"Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis","volume":"95","author":"Andreucci","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1158\/1078-0432.CCR-08-0374","article-title":"Gefitinib induction of in vivo detectable signals by Bcl-2\/Bcl-xL modulation of inositol trisphosphate receptor type 3","volume":"14","author":"Zannetti","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"D\u2019Alterio, C., Zannetti, A., Trotta, A.M., Ieran\u00f2, C., Napolitano, M., Rea, G., Greco, A., Maiolino, P., Albanese, S., and Scognamiglio, G. (2020). New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer. Cancers, 12.","DOI":"10.3390\/cancers12071952"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Hill, B.S., Sarnella, A., Capasso, D., Comegna, D., Del Gatto, A., Gramanzini, M., Albanese, S., Saviano, M., Zaccaro, L., and Zannetti, A. (2019). Therapeutic Potential of a Novel \u03b1v\u03b2\u2083 Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type. Cancers, 11.","DOI":"10.3390\/cancers11020139"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13046-020-01694-9","article-title":"Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer","volume":"39","author":"Camorani","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9874","DOI":"10.1021\/acs.jmedchem.7b01590","article-title":"Chemical Modification for Proteolytic Stabilization of the Selective \u03b1v\u03b23 Integrin RGDechi Peptide: In Vitro and in Vivo Activities on Malignant Melanoma Cells","volume":"60","author":"Comegna","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00259-003-1381-0","article-title":"Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines","volume":"31","author":"Aloj","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","article-title":"Triple negative breast cancer: Pitfalls and progress","volume":"8","author":"Zagami","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Camorani, S., Fedele, M., Zannetti, A., and Cerchia, L. (2018). TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities. Pharmaceuticals, 11.","DOI":"10.3390\/ph11040123"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Wu, Q., Siddharth, S., and Sharma, D. (2021). Triple Negative Breast Cancer: A Mountain Yet to Be Scaled Despite the Triumphs. Cancers, 13.","DOI":"10.3390\/cancers13153697"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.semcancer.2019.07.028","article-title":"Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer","volume":"60","author":"Hill","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"532161","DOI":"10.1155\/2014\/532161","article-title":"Mesenchymal stem cell-induced doxorubicin resistance in triple negative breast cancer","volume":"2014","author":"Chen","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.omto.2020.10.008","article-title":"Mesenchymal Stem Cell-Secreted Exosome Promotes Chemoresistance in Breast Cancer via Enhancing miR-21-5p-Mediated S100A6 Expression","volume":"19","author":"Luo","year":"2020","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/s41388-020-01574-8","article-title":"MSC-induced lncRNA AGAP2-AS1 promotes stemness and trastuzumab resistance through regulating CPT1 expression and fatty acid oxidation in breast cancer","volume":"40","author":"Han","year":"2021","journal-title":"Oncogene"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1038\/s41388-022-02385-9","article-title":"Effects of iron modulation on mesenchymal stem cell-induced drug resistance in estrogen receptor-positive breast cancer","volume":"41","author":"Buschhaus","year":"2022","journal-title":"Oncogene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1038\/s41467-022-31704-7","article-title":"A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1186\/s12885-019-6278-9","article-title":"Cisplatin-resistant triple-negative breast cancer subtypes: Multiple mechanisms of resistance","volume":"19","author":"Hill","year":"2019","journal-title":"BMC Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s13046-021-02039-w","article-title":"Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors","volume":"40","author":"Agnello","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"103327","DOI":"10.1016\/j.critrevonc.2021.103327","article-title":"Tumor hypoxia: The major culprit behind cisplatin resistance in cancer patients","volume":"162","author":"Devarajan","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_38","first-page":"9142","article-title":"Tumor-derived mesenchymal-stem-cell-secreted IL-6 enhances resistance to cisplatin via the STAT3 pathway in breast cancer","volume":"15","author":"Xu","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.7150\/jca.37932","article-title":"Mesenchymal stem\/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression","volume":"11","author":"Zeng","year":"2020","journal-title":"J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2015.10.018","article-title":"A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion","volume":"370","author":"Fontanella","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Pelagalli, A., Nardelli, A., Fontanella, R., and Zannetti, A. (2016). Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17071102"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.7150\/thno.27798","article-title":"Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFR\u03b2 aptamer","volume":"8","author":"Camorani","year":"2018","journal-title":"Theranostics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13046-022-02345-x","article-title":"Inhibition of carbonic anhydrases IX\/XII by SLC-0111 boosts cisplatin effects in hampering head and neck squamous carcinoma cell growth and invasion","volume":"41","author":"Sarnella","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13058-022-01532-0","article-title":"Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer","volume":"24","author":"Ong","year":"2022","journal-title":"Breast Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14756366.2018.1532419","article-title":"The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy","volume":"34","author":"Andreucci","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Boyd, N.H., Walker, K., Fried, J., Hackney, J.R., McDonald, P.C., Benavides, G.A., Spina, R., Audia, A., Scott, S.E., and Libby, C.J. (2017). Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight, 2.","DOI":"10.1172\/jci.insight.92928"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","article-title":"Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells with Activated KRAS in Response to Hypoxia","volume":"157","author":"McDonald","year":"2019","journal-title":"Gastroenterology"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/2\/298\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:04:30Z","timestamp":1760119470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/12\/2\/298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,12]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["cells12020298"],"URL":"https:\/\/doi.org\/10.3390\/cells12020298","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,12]]}}}